# A Study to Assess Safety, Tolerability, and Pharmacokinetics of Orally Administered GCC4401C in Healthy Volunteers

> **NCT01651234** · PHASE1 · COMPLETED · sponsor: **Green Cross Corporation** · enrollment: 48 (actual)

## Conditions studied

- Healthy Male

## Interventions

- **DRUG:** GCC-4401
- **DRUG:** GCC-4401C

## Key facts

- **NCT ID:** NCT01651234
- **Lead sponsor:** Green Cross Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-03
- **Primary completion:** 2012-08
- **Final completion:** 2012-08
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2012-08-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01651234

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01651234, "A Study to Assess Safety, Tolerability, and Pharmacokinetics of Orally Administered GCC4401C in Healthy Volunteers". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01651234. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*